These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8642166

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H, Gedizlioglu M, Akyel S, Aslaner T, Eser E.
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Psychometric comparison of standard and computerized administration of the Alzheimer’s Disease Assessment Scale: Cognitive Subscale (ADASCog).
    O'Halloran JP, Kemp AS, Salmon DP, Tariot PN, Schneider LS.
    Curr Alzheimer Res; 2011 May; 8(3):323-8. PubMed ID: 21314622
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reliability and Photographic Equivalency of the Scar Cosmesis Assessment and Rating (SCAR) Scale, an Outcome Measure for Postoperative Scars.
    Kantor J.
    JAMA Dermatol; 2017 Jan 01; 153(1):55-60. PubMed ID: 27806156
    [Abstract] [Full Text] [Related]

  • 7. Reliability of the Alzheimer's disease assessment scale (ADAS-Cog) in longitudinal studies.
    Khan A, Yavorsky C, DiClemente G, Opler M, Liechti S, Rothman B, Jovic S.
    Curr Alzheimer Res; 2013 Nov 01; 10(9):952-63. PubMed ID: 24117118
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].
    Papp E, Pákáski M, Drótos G, Kálmán J.
    Psychiatr Hung; 2012 Nov 01; 27(6):426-34. PubMed ID: 23429337
    [Abstract] [Full Text] [Related]

  • 14. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
    Karin A, Hannesdottir K, Jaeger J, Annas P, Segerdahl M, Karlsson P, Sjögren N, von Rosen T, Miller F.
    Acta Neurol Scand; 2014 Feb 01; 129(2):114-22. PubMed ID: 23763450
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.
    Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B.
    Neurology; 1998 May 01; 50(5):1222-30. PubMed ID: 9595967
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.